If you are a device manufacturer dealing with the high failure rates of manual sphincters—this project developed UroActive™, a smart implant that replaces manual manipulation with remote control to reduce mechanical wear and patient humiliation.
Smart Wireless Implant for Severe Stress Urinary Incontinence Treatment
Imagine a smart valve for the body that stops leaks without needing to manually squeeze a pump in your groin. Instead of old-fashioned mechanical parts, this device uses a remote control or a simple tap on the stomach to let someone go to the bathroom. It also automatically adjusts its pressure based on whether the person is sitting or moving to prevent injuries.
What needed solving
Current artificial urinary sphincters are archaic, requiring humiliating manual manipulation and causing high rates of tissue erosion. Mesh slings for women are plagued by safety issues, leading to over 100,000 lawsuits in the USA.
What was built
The UroActive™ smart artificial urinary sphincter, featuring remote control, automatic pressure adjustment, and wireless parameter tuning.
Who needs this
Who can put this to work
If you are a clinic dealing with the 15% failure rate of mesh slings in women—this project developed a personalized, wirelessly adjustable sphincter that provides a safer alternative to banned or litigated mesh products.
If you are a developer dealing with the lack of connectivity in urological implants—this project developed a connected system where surgeons can wirelessly adjust parameters after implantation to improve patient outcomes.
Quick answers
What is the cost or pricing of the UroActive device?
Based on available project data, there is no specific pricing or cost information provided.
Can this be produced at an industrial scale?
The project is led by UROMEMS, an SME focused on MEMS technology, but specific industrial scaling capacity is not detailed in the report.
What is the IP or licensing status of the technology?
Based on available project data, the specific patent or licensing terms are not listed, though the technology is developed by UROMEMS.
How does the device handle safety and regulation?
The device includes a safety feature that automatically opens if the patient loses consciousness to prevent bladder overpressure and kidney injury.
What is the timeline for market entry?
The project period was from 2023-07-01 to 2024-12-31, but a commercial launch date is not specified.
Who built it
The project is managed by a single-partner consortium consisting of UROMEMS, a French SME. This 100% industry-led structure suggests a strong focus on commercialization and direct application of MEMS technology rather than academic exploration.
Contact UROMEMS in France
Talk to the team behind this work.
Contact us to explore licensing opportunities for UroActive™